Latest "Auxilium" News Stories

01:24 EDT 23rd March 2018 | BioPortfolio

Here are the most relevant search results for "Auxilium" found in our extensive news archives from over 250 global news sources.

More Information about Auxilium on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Auxilium for you to read. Along with our medical data and news we also list Auxilium Clinical Trials, which are updated daily. BioPortfolio also has a large database of Auxilium Companies for you to search.

Showing "Auxilium" News Articles, all 4

Tuesday 2nd January 2018

Dr. Philippe Chambon Joins Pharnext’s Board of Directors

Regulatory News: Pharnext SA (Paris:ALPHA) (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and repositioning of known drugs, today announced its board of directors has appointed Dr. Philippe Chambon as a new, independent, non-executive member. He i...

Friday 17th November 2017

Endo unit cleared of liability in first testosterone replacement trial

NEW YORK: A federal jury in Chicago said on Thursday that Endo International's Auxilium unit was not responsible for the heart attack a man suffered while using the company's testosterone replacement drug Testim. The verdict was a victory for the drugmaker in its first trial over allegations it defectively designed Testim, a skin gel, and negligently misrepresented its risks.

Tuesday 7th November 2017

Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results And Provides Business Update

Completed Initial Public Offering Raising $103.5 million in gross proceeds Submitted New Drug Application to U.S. Food and Drug Administration for INVELTYS™ (KPI-121 1%) Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary muc...

Friday 20th October 2017

Fortress Biotech (FBIO) & Auxilium Pharmaceuticals (AUXL) Critical Comparison

Fortress Biotech and Auxilium Pharmaceuticals are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. This is a breakdown of current ratings and price targets for Fortress Biotech and Auxilium Pharmaceuticals, as report...

Quick Search


News Quicklinks